Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 219 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/29/21
End: 02/17/25
Due: 02/17/26
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 02/28/09
Due: 02/28/10
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 06/30/16
Due: 06/30/17
A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines
Phase: N/A
Priority: Normal
Start: 09/27/21
End: 07/18/22
Due: 07/18/23
Phase: N/A
Priority: Normal
Start: 01/17/19
End: 03/15/19
Due: 03/15/20
Phase: N/A
Priority: Normal
Start: 04/17/18
End: 02/22/19
Due: 02/22/20
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 08/23/21
End: 12/29/21
Due: 12/29/22
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 07/31/10
Due: 07/31/11
Phase: N/A
Priority: Normal
Start: 11/17/17
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 07/31/04
End: 09/30/05
Due: 09/30/06
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 10/08/18
Due: 10/08/19
Phase: N/A
Priority: Normal
Start: 09/12/23
End: 11/21/23
Due: 11/21/24
Phase: N/A
Priority: Normal
Start: 01/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/05/22
End: 02/19/22
Due: 02/19/23
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 12/03/24
End: 10/25/29
Due: 10/25/30
Phase: N/A
Priority: Normal
Start: 08/28/18
End: 12/24/18
Due: 12/24/19
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 03/13/25
Due: 03/13/26
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 06/30/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 06/16/17
End: 01/03/18
Due: 01/03/19